These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 18765686

  • 1. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH, Jung SY, Lee YJ, Song KJ, Kwon D, Kim K, Park S, Im KI, Shin HJ.
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH, Lee YJ, Sohn HJ, Song KJ, Kwon D, Kwon MH, Im KI, Shin HJ.
    Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
    [Abstract] [Full Text] [Related]

  • 3. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Goswick SM, Brenner GM.
    J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
    [Abstract] [Full Text] [Related]

  • 4. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
    Peroutka-Bigus N, Bellaire BH.
    J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
    [Abstract] [Full Text] [Related]

  • 5. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
    Debnath A, Tunac JB, Galindo-Gómez S, Silva-Olivares A, Shibayama M, McKerrow JH.
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL, Guglielmo BJ, Visvesvara GS.
    J Eukaryot Microbiol; 2006 Nov; 53(2):121-6. PubMed ID: 16579814
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fatal primary meningoencephalitis caused by Naegleria fowleri.
    Shariq A, Afridi FI, Farooqi BJ, Ahmed S, Hussain A.
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):523-5. PubMed ID: 25052979
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi.
    Cárdenas-Zúñiga R, Silva-Olivares A, Villalba-Magdaleno JA, Sánchez-Monroy V, Serrano-Luna J, Shibayama M.
    Microbiology (Reading); 2017 Jul; 163(7):940-949. PubMed ID: 28721850
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic glycan-specific antibody binding mediates protection during primary amoebic meningoencephalitis.
    Moseman AP, Chen C-w, Liang X, Liao D, Kuraoka M, Moseman EA.
    Infect Immun; 2024 Oct 15; 92(10):e0018324. PubMed ID: 39235225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.